Display # 
Cannabis Science Signs Gary Blick, MD and Proceeds With CS-TATI-1 for HIV and Kaposi Sarcoma Drug Development Program 29 Jul 2015
Mark Wainberg, Ph.D., Joins Cannabis Science's Scientific Advisory Board; Cannabis Science Presents Further Dimensions of CS-TATI-1 Discovery Platform at 8th IAS Conference on HIV Pathogenesis 23 Jul 2015
Cannabis Science, Inc. Initiates the Scientific Validation of the Biological Impact of Cannabinoids in Order to Better Define the Therapeutic Mechanism of Action Using Biochemical, Cell, and Genetic Approaches 17 Jul 2015
Cannabis Science Signs Research & Distribution Agreement for California and Announces Guidance for Its New Product Releases in California and International Cannabinoid Research Operations 16 Jul 2015
Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development Deal With IGXBio and Its GenePro®, a DNA-Based Immunotherapeutic that Recently Received FDA Approval to Enter into Human Trials 27 May 2015
CBIS Expands Licensing Deal with Purple Haze Properties as it Launches 'Jimi's Cannabis Collection' Today at the Chicago 'Marijuana Business Conference and Expo' 19 May 2015
Cannabis Science Acquires Pet Care Manufacturer and Distributor Equi-Pharm & Enters the $60 Billion Pet Care Industry 07 May 2015
Cannabis Science (CBIS) Accepted To Present at ICAR 2015 22 Apr 2015
Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives 31 Mar 2015
After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest 26 Mar 2015